Rick Simpson Oil (RSO) in Kalawao County, Hawaii: The Complete Guide by OilWell Cannabis

Understanding RSO and Its Roots in Personal Healing

Kalawao County, with its deep history of healing and resilience on Molokai’s remote northern peninsula, understands better than most places that true medicine often emerges from desperation. When conventional systems fail, communities find their own paths forward. That’s exactly how Rick Simpson Oil began—not in a pharmaceutical lab or university research center, but in the workshop of a power engineer in Nova Scotia who had been failed by the medical system, much like many residents in isolated communities across Hawaii have experienced when specialist care requires inter-island travel or when treatments simply don’t work.

Rick Simpson was born in 1949 in Amherst, Nova Scotia, a blue-collar tradesman, not a doctor or scientist. His journey into cannabis advocacy started in 1997 after a scaffolding fall at a Moncton hospital left him with persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. The medications prescribed either didn’t help or made things worse. Cannabis provided relief where pharmaceuticals failed, yet his physician refused to consider it—a scenario that resonates across Kalawao County’s limited healthcare infrastructure, where patients often wait weeks for specialist appointments on Oahu or Maui and sometimes find themselves exploring alternatives when the system falls short.

Simpson’s interest deepened after learning about a 1974 NIH-funded study at the Medical College of Virginia where THC reportedly slowed tumors in mice. That study, intended to demonstrate harm, became his reference point despite never being replicated in human trials. Then came 2003, when three bumps on his arm were diagnosed as basal cell carcinoma. Applying concentrated cannabis oil directly, he claimed they disappeared within four days. No independent medical verification exists—no biopsy confirmation, no peer-reviewed documentation. Yet this personal testimony became the catalyst for a global movement, much like how word-of-mouth healing stories travel through tight-knit Hawaiian communities from Kaunakakai to the remote valleys of Halawa.

Important Context: Simpson’s account is personal testimony, not medical evidence. The absence of clinical documentation means these events cannot be evaluated as scientific proof, but they remain historically significant as the spark that ignited worldwide interest in concentrated cannabis oil.

The RSO Movement: From One Man to Global Phenomenon

After his 2003 experience, Simpson committed himself to producing and distributing oil for free from his Maccan, Nova Scotia property—charging nothing for a product he claimed helped dozens with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more. This free-distribution model resonates deeply in Kalawao County’s culture of mutual aid and community support, where neighbors still share resources across remote homesteads and look after each other’s keiki and kupuna.

The 2005 documentary Run From The Cure, directed by Christian Laurette, introduced Simpson’s story to global audiences. Distributed freely online, it became foundational in cannabis communities worldwide—many people in Hawaii first learned about RSO through this film shared across community networks, long before dispensaries arrived on Oahu.

Simpson’s advocacy brought him into direct conflict with Canadian law. RCMP raids in 2005 and 2009 resulted in charges for cultivation, possession, and trafficking. Eventually, he left Canada for Europe, continuing advocacy from Croatia and the Netherlands. In 2012, he published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his platform .

Throughout his career, Simpson maintained an uncompromising position: RSO could cure cancer and many diseases, with pharmaceutical companies and government agencies suppressing this knowledge. He framed his work as fighting institutional corruption—a worldview shared by many in the early cannabis movement, particularly in isolated communities that have historically faced systemic neglect.

Important Context: Simpson’s conspiratorial framing reflects a worldview shaped by institutional failure, not unlike how some in Kalawao County’s remote communities have experienced limited healthcare access and bureaucratic indifference. While we acknowledge this perspective, our commitment at OilWell is to evidence-based education rather than rhetoric.

The Traditional RSO Protocol: 60 Grams Over 90 Days

Simpson’s core recommendation was consuming 60 grams of oil over approximately 90 days. For Kalawao County residents considering this path, understanding the details is crucial because island life demands practical knowledge—knowing exactly what you’re doing before you start, whether it’s fishing, farming, or exploring cannabinoid therapy.

Goal: 60 grams (approximately 60 mL) of concentrated, high-THC cannabis oil over ~90 days.

Titration Schedule:

• Week 1: Half a grain of rice-sized dose (10-15 mg) three times daily—total ~30-45 mg/day
• Weeks 2-5: Double every four days, targeting ~1 gram/day by week 5 (1,000 mg divided into three doses)
• Weeks 5-12: Maintain 1 gram/day until all 60 grams consumed

Administration Methods:

• Oral/Sublingual: Primary route for systemic absorption—under the tongue or swallowed
• Topical: For skin cancers—direct application with bandage changes every 3-4 days
• Inhalation: Not recommended as primary treatment, though acknowledged for immediate symptom relief

Tolerance & Psychoactive Effects: Simpson claimed patients develop tolerance within 3-4 weeks, with the “high” being temporary. He recommended initial nighttime dosing and warned against driving during titration—practical advice that Kalawao County residents, who navigate narrow cliffside roads between Kalaupapa and topside Molokai, should take seriously.

Post-Protocol Maintenance: After completing 60 grams, Simpson recommended 1-2 grams monthly indefinitely.

Dietary Recommendations: General advice to reduce sugar and processed foods—common-sense wellness guidance that aligns with traditional Hawaiian healing philosophies emphasizing whole foods and natural living.

Critical Context for Evaluating This Protocol

This protocol was designed by one person based on personal experience, not clinical trials. Several realities Kalawao County residents must understand:

• No controlled trial validation—no published randomized controlled trials or cohort studies exist for this specific 60-gram/90-day protocol
• Crude, unstandardized material—THC content varied wildly (60-90% estimated) depending on starting plant material
• Extremely high THC exposure—600-900 mg delta-9 THC daily at peak dosing, far exceeding FDA-approved dronabinol (2.5-20 mg/day)
• Real risks—severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder are documented at these doses [1][13][14][15]
• Oncology complexity—patients with active cancer are medically complex; using unregulated oil as primary treatment could delay proven therapies with serious consequences

For Kalawao County residents dealing with cancer, it’s vital to consult with oncology specialists. While Molokai’s small community may require travel to Maui or Oahu for treatment, proven medical care should never be replaced with any cannabis product, including RSO.

About Traditional RSO: The Product Itself

Traditional RSO was defined by method, not lab specs—crucial for Kalawao County residents to understand when evaluating what’s sold today.

Source Material: High-THC indica strains, no standardization. Simpson favored sedating indica genetics, believing they worked better for cancer treatment.

Extraction Solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol—neither food-grade. This is perhaps the most significant safety concern, especially for Kalawao County residents who may encounter DIY makers in remote areas where access to tested products is limited.

Extraction Process:

1. Cannabis in bucket
2. Cover with solvent, agitate
3. Filter through cheesecloth
4. Repeat with fresh solvent
5. Evaporate in rice cooker
6. Transfer to syringes

The heat evaporated solvent at temperatures sufficient to convert all THCa to THC and destroy most terpenes.

Appearance: Nearly black, thick, tar-like, sticky oil with strong cannabis odor and possible solvent-residual smell.

Cannabinoid Profile:

• Fully decarboxylated delta-9 THC (60-90% estimated)
• Naturally occurring minor cannabinoids at uncontrolled ratios
• No ratio control, no lab verification

Terpene Content: Minimal to none—destroyed by solvent and heat.

Standardization & Testing: None. Every batch differed based on plant material, growing conditions, solvent purity, technique, and maker skill.

Residual Solvent Risk: Naphtha may contain benzene, toluene, and other toxic/carcinogenic compounds. Incomplete purging is dangerous and hard to verify without lab equipment—critical for Kalawao County residents considering home production.

Evidence Evaluation: Claims vs. Reality

Rick Simpson made expansive claims: RSO could cure cancer, diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, MS, and more . But what does the evidence actually show?

What Simpson Was Not

He was not a scientist, physician, pharmacologist, or researcher. He had no formal medical training, never conducted or published a clinical trial, and never submitted results for peer review. His evidence base was personal experience and informal testimonials—no controls, no verification, no long-term follow-up.

What Preclinical Literature Shows

Laboratory and animal studies demonstrate that THC and CBD can induce apoptosis (programmed cell death), inhibit proliferation, and reduce angiogenesis in certain cancer cell lines . Animal models show some tumor-growth inhibition. This generates legitimate scientific interest but does not translate to proven human cancer cures.

What Preclinical Literature Does NOT Show

No human clinical trial has demonstrated that RSO or any cannabis oil cures cancer. The gap between in vitro/animal results and human outcomes is vast across all oncology research. Small human trials of cannabinoids in cancer (particularly glioblastoma) have been exploratory and haven’t produced results supporting cure claims .

Institutional Positions

• National Cancer Institute (NCI): Acknowledges anticancer research in labs and animals but does not endorse cannabis as cancer treatment
• FDA: Has not approved any cannabis plant product for cancer; only Epidiolex (CBD) for seizures and synthetic THC analogues for chemo nausea/AIDS wasting [1]
• Health Canada: Never approved RSO for cancer
• NCCIH: Strongest evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure [1]

What Simpson Got Right

He drew attention to cannabinoids as serious biomedical research when the world ignored them. His advocacy helped create conditions for the legal cannabis industry and research infrastructure we have today. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What He Overstated

The leap from preclinical signals to cancer cure was never supported by human evidence. Encouraging patients—especially cancer patients—to rely on RSO in place of proven oncologic therapies (surgery, radiation, chemotherapy, immunotherapy) carries genuine harm potential. Delayed treatment for treatable cancers is a documented concern in alternative medicine.

The Modern RSO Evolution: Why OilWell’s Formulas Diverge

Traditional RSO was a crude, unstandardized extract. Modern formulations like ours represent deliberate, evidence-motivated evolution:

Multi-Cannabinoid Approach: Traditional RSO used whatever single strain was available. OilWell includes seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—reflecting entourage-effect literature suggesting potential benefit from cannabinoid diversity, though robust clinical proof of whole-formula synergy remains limited [20][29].

Terpene Preservation: Traditional RSO had essentially no terpenes due to heat destruction. OilWell includes live terpenes at 5% with a specific seven-terpene profile because terpene bioactivity is plausible at the preclinical level, even if human clinical confirmation is still developing [20][21][23][24][25][26][27][28][29].

THCa as Separate Ingredient: Traditional RSO fully decarboxylated everything. OilWell preserves THCa at 1,500 mg as a distinct ingredient because the THCa literature suggests potentially relevant non-psychoactive bioactivity that is lost when it converts to THC [12].

Reduced Delta-9 THC Dominance: Traditional RSO was 60-90% delta-9 THC. OilWell uses only 90 mg delta-9 THC while distributing cannabinoid content across the others—a modern approach reflecting broader research rather than single-compound dominance.

Product Format Innovation: Simpson envisioned only oral oil. OilWell offers both sublingual oil and vape cartridge, acknowledging that different delivery routes have different pharmacokinetic profiles [14].

Solvent Safety: From Toxic Chemicals to Food-Grade Production

Traditional RSO’s naphtha/isopropyl alcohol extraction posed significant risks. Naphtha contains benzene, toluene, and other toxic compounds. Modern extraction uses food-grade ethanol or supercritical CO₂ with validated testing methods like headspace gas chromatography.

OilWell’s RSO isn’t an extraction product at all—it’s a formulated blend of individual cannabinoid distillates combined in controlled environment. No solvents remain. We use organic MCT oil as carrier, providing neutral taste and better absorption than tar-like traditional RSO.

THCa Preservation: The Non-Psychoactive Advantage

Traditional RSO’s high-heat process converted all THCa to THC. OilWell’s sublingual formula deliberately preserves 1,500 mg THCa because:

• THCa itself doesn’t produce psychoactive effects associated with THC [12]
• It offers anti-inflammatory activity via COX-2 inhibition [12]
• Provides neuroprotective potential via PPARγ agonism [12]

For Kalawao County residents who work at Kalaupapa National Historical Park, drive the winding roads, or care for families during the day, this means access to therapeutic cannabinoids without impairment.

Terpene Loss: What Traditional RSO Missed

Terpenes volatilize at temperatures well below cannabinoid degradation points. Traditional RSO production—dissolving terpenes into solvent then evaporating—effectively stripped them away.

OilWell’s formulas specify live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each has distinct aromatic and potential bioactive properties that enhance the experience.

About OilWell Cannabis: Our Foundation in Real Healing

The Origin: From McAllen to Houston to Kalawao County

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas—right across from Reynosa, Tamaulipas, Mexico in the Borderplex, one of the most economically challenged and dangerous regions along the U.S.-Mexico border. McAllen is a city of contrasts: vibrant culture alongside poverty and limited opportunities beyond retail and healthcare. Reynosa is an industrial hub plagued by cartel violence.

Colin’s childhood involved transporting items across the border, experiencing every form of violence imaginable. By sixteen, he had to leave home for good. Many of his best friends have been killed or are in prison. He faced those dangers daily but chose cannabis over harder substances, seeing it as a safer alternative.

He later became a formally trained software engineer, doing custom development for Baylor College of Medicine in the Texas Medical Center—combining deep cannabis plant knowledge with medical-grade technical precision.

Bentley: The Dog Who Started Everything

The company’s origin story begins with Bentley, more than a pet—family. When veterinarians diagnosed Bentley with paralysis and recommended euthanasia, Colin refused. They warned pain medications would destroy his organs. The choice was painful prolonged decline or immediate mercy killing.

In desperation, rescue worker Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?” That question exposed a blind spot that became a mission.

Colin created CBD golden paste for pets. It wasn’t a cure but a lifeline—and hope delivered the impossible: Bentley got up, walked over, and brought his ball to play. From paralyzed to fetching—dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals couldn’t.

Bentley lived ten more years, dying naturally at twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis → Multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene through different receptor systems

Single cannabinoids weren’t enough. Bentley’s conditions required multi-cannabinoid synergy. CBD alone couldn’t address neurodegeneration, dementia, glaucoma, and arthritis simultaneously. Minor cannabinoids became critical. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

Colin’s Personal Journey: PTSD, Benzo Addiction, and Healing

Colin knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he quit Xanax cold turkey—a notoriously difficult and dangerous feat—he used the cannabinoid knowledge developed keeping Bentley alive.

The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD. This is not theoretical knowledge. He lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills don’t.

Doctors Use Our Formulas

Over time, therapeutic benefits expanded beyond pets. Colin developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. Focus has always been on making cannabis accessible for everyone—vegans, diabetics, those with specific health needs.

ABC13: Seven Features Across Four Years

ABC13 KTRK Houston featured OilWell in seven comprehensive segments (2019-2023), covering Texas marijuana law, Delta-8 legal analysis, COVID-19 community health leadership, criminal justice reform, and cannabis business pioneering. Colin was repeatedly selected as primary industry expert in America’s fourth-largest city.

The Foundational Quote (September 2019): “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

This quote is the seed of everything OilWell became—open-source formulas, evidence-based documentation, refusal to make unsupported claims.

Current Operations: Real Business, Real Impact

OilWell Cannabis operates from Montrose, Houston (810 Richmond Avenue, Houston, TX 77006). Since 2019, we’ve generated approximately $1M annual revenue, maintain a near-5.0 Google rating, and hold Texas DSHS licensing. Products aren’t mass-produced—they’re carefully crafted with personal touch, from packaging artwork to formulations. All created in-house in Houston using only our own recipes.

Colin brings Houston grit, McAllen roots, and a builder’s mindset to the company. The posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone.

The OilWell RSO Philosophy: Four Core Principles

Our RSO is not traditional Rick Simpson Oil. It’s a formulated, multi-cannabinoid product informed by tradition but departing deliberately to solve problems that limited Simpson’s original vision.

1. Accessibility Over Gatekeeping

No medical card required. Anyone 21+ can purchase. We ship nationwide across the United States and internationally to customers who verify local legality. Simpson believed medicine should be accessible; we built a product and distribution model making that legally possible.

For Kalawao County residents: This means you don’t need to qualify for Hawaii’s medical cannabis program. You can access our RSO regardless of whether you have a qualifying condition under state law.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate into delta-9 THC for full psychoactive potency. Simpson believed patients should control their medicine; we engineered a product putting that control in your hands through chemistry, not rhetoric.

For Kalawao County residents: Whether you’re working at the Molokai Plumeria Farm, caring for family, or operating a tour business, you can choose non-psychoactive daytime use or full-potency nighttime relief from the same bottle.

3. Open-Source Formulas

We publish complete formulas publicly—every cannabinoid, every milligram, every percentage—so anyone who cannot afford the product can source ingredients and make their own. Simpson gave oil away free and taught people to make it; we adapted that ethos for the modern marketplace.

For Kalawao County residents: If $129.99 is beyond your budget, you have the recipe. This aligns with Molokai’s tradition of self-sufficiency and community sharing.

4. Evidence-Informed, Not Evidence-Overstating

The GENERAL KNOWLEDGE section in this document represents our commitment to honest education about what science actually says. Simpson operated without peer-reviewed literature; we have that access and use it to distinguish what is well-supported, emerging, or overstated.

Farm Bill Compliance and the THCa Legal Framework

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level—critical for Kalawao County residents navigating Hawaii’s complex cannabis laws.

Our RSO Sublingual Oil contains only 90 mg delta-9 THC in the entire 30 mL bottle (3 mg/mL)—well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in most states, including Hawaii.

THCa (tetrahydrocannabinolic acid) is the acidic, non-psychoactive precursor to delta-9 THC. It’s not itself delta-9 THC, making it Farm Bill compliant at sale because it hasn’t been converted.

The Practical Magic for Kalawao County: You can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg, you get ~1,405 mg total delta-9 THC—psychoactive potency comparable to traditional illegal RSO, 100% legally, because decarboxylation occurs at your discretion after purchase.

The same product functions as non-psychoactive anti-inflammatory (raw) or full-potency psychoactive medicine (decarbed). You control the decision. This product is legal everywhere component cannabinoids are legal, enabling international shipping to jurisdictions permitting hemp-derived products with <0.3% delta-9 THC.

Important Legal Notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with Hawaii state laws regarding cannabinoid products. OilWell ships with full documentation, Certificates of Analysis, and receipts.

How to Access OilWell RSO in Kalawao County

Shipping to Hawaii and Kalawao County

While we don’t have same-day delivery to Kalawao County like we do in Houston, we ship reliably to Hawaii via USPS Priority Mail (2-3 business days) and FedEx/UPS Ground (3-5 business days). All packages are:

• Discreetly packaged with no cannabis branding visible
• Temperature-stable for Hawaii’s warm climate
• Tracked with signature-required options available
• Include full documentation and COAs for Hawaii’s agricultural inspection requirements

International Shipping: We ship worldwide and have delivered to multiple countries across continents. International customers accept all customs and legal responsibility. Contact: (832) 416-2816 or [email protected].

The Decarboxylation Choice: Three Paths from One Product

Option 1—Raw (No Heat): All 1,500 mg stays as THCa—completely non-psychoactive. Perfect for Kalawao County residents who need daytime functionality without impairment.

Option 2—Fully Activated (Home Decarb): Heat at 260°F for 45-60 minutes converts THCa to ~1,315 mg delta-9 THC + 90 mg existing = ~1,405 mg total. Achieves traditional RSO potency at your discretion.

Option 3—Vape (Auto-Decarb): Our RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff—fastest relief available.

Conversion Chemistry: 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation (accounting for CO₂ loss).

Solvent-Free Production: Safety First

Traditional RSO’s naphtha/isopropyl extraction posed serious health risks. OilWell’s RSO is a formulated blend of individual cannabinoid distillates—no solvents remain. We use organic MCT oil as carrier, providing neutral taste and better absorption than tar-like traditional RSO.

Third-party lab testing covers:

• Cannabinoid potency
• Terpene profile
• Pesticides (400+ compounds)
• Heavy metals (arsenic, cadmium, lead, mercury)
• Residual solvents (FDA Class 3 limits <5,000 ppm)
• Microbial contaminants (E. coli, Salmonella, Aspergillus)

Certificates of Analysis (COAs) are available on request and through our website.

Condition-Specific Usage Context for Kalawao County Residents

Important Disclaimer: These contexts are informed by cannabinoid research cited in our GENERAL KNOWLEDGE section. Not FDA-approved treatment protocols. Not a substitute for professional medical care. Always consult a qualified healthcare provider. Do not operate vehicles or machinery while under psychoactive cannabinoid influence.

Chemotherapy-Related Nausea and Appetite Support

Typical Kalawao County Scenario: Traveling to Maui or Oahu for chemo treatment, needing relief during and after sessions.

• Pre-chemo: 0.5-1.0 mL sublingual ~1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0 mL before bed (delivers 25-50 mg CBN)

Evidence: Delta-8 THC antiemetic [9], delta-9 THC nausea reduction [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

Typical Kalawao County Scenario: Physical labor in agriculture, fishing, or tourism causing chronic joint and back pain.

• Daytime: 0.3-0.5 mL raw sublingual—anti-inflammatory without psychoactive impairment
• Nighttime: 0.5-1.0 mL decarbed sublingual—pain relief plus CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence: CBD pain reduction [4], delta-9 THC analgesia [13], beta-caryophyllene CB2 activation [24], THCa COX-2 inhibition [12]

Sleep Support

Typical Kalawao County Scenario: Quiet nights in remote areas but stress and pain disrupting sleep.

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: 50 mg CBN (dosage level in 2024 sleep literature)
• At 1.0 mL: 25 mg CBN (above threshold associated with reduced sleep disturbance [16][17])

Anxiety and Stress

Typical Kalawao County Scenario: Economic uncertainty in a remote community, isolation, and the weight of caring for family across islands.

• Daytime functional relief: 0.3 mL raw sublingual—CBD and CBG address anxiety without impairment
• Nighttime: 1.0 mL sublingual—full profile including CBN for sleep architecture

Evidence: CBD anxiolytic [3], CBG pharmacology [7][8], limonene entourage effect [20]

General Titration Principle for Kalawao County

Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary by body weight, metabolism, tolerance, and concurrent medications—particularly important in Kalawao County where some residents may have slower metabolisms due to genetic factors or be taking other medications for chronic conditions common in remote island communities.

The Evidence Base: What Science Actually Says

Research Method and Evidence Weighting

Our approach prioritizes: human clinical evidence → systematic reviews → institutional summaries → preclinical literature. This matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human data; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes rely more on reviews and animal work [1]-[29].

Institutional Baseline: NIH and Related Sources

• NCCIH: Strongest evidence for rare epilepsies, chemo nausea, HIV/AIDS appetite. Modest evidence for chronic pain and MS symptoms [1]
• FDA: No cannabis plant approvals; only Epidiolex (CBD) for seizures and synthetic THC analogues for chemo nausea/AIDS wasting [1]
• Safety concerns: Impairment, vehicle crash risk, cannabis use disorder, pregnancy concerns, contamination, labeling inaccuracy, vape lung injury [1]

Cannabinoids: The Real Science

CBD (Cannabidiol)

Strongest evidence in our formula. Purified CBD has credible human evidence in seizure disorders [1][2]. Anxiety research shows statistically significant anxiolytic signal in a 2024 meta-analysis of 316 participants, but authors stress limited clinical samples require more trials [3]. Pain literature is promising but heterogeneous [4]. Sleep research remains methodologically weak [5].

Safety: 2023 meta-analysis found liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products [6]. NCCIH flags diarrhea, sleepiness, appetite change, mood effects, liver abnormalities, and drug interactions [1].

CBG (Cannabigerol)

Mostly review and preclinical. Pharmacology shows interactions with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling—mechanistically interesting but not clinically established [7]. Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are hypotheses or preclinical findings [7][8]. Key caution: CBG is commercially sold while evidence remains thin [7].

Delta-8 THC

Pharmacologically relevant, psychoactive, less clinically characterized than delta-9. 2022 review found similar pharmacokinetic/pharmacodynamic behavior to delta-9 but less potent, likely due to weaker CB1 affinity [9]. 2023 scoping review noted adverse consequences and regulatory/product-quality concerns [10]. 2024 chemistry review emphasized manufacturing interest due to stability and easier synthesis from hemp [11].

Bottom line: Delta-8 is psychoactive with real pharmacologic activity but incomplete human safety characterization and manufacturing-quality uncertainty [9]-[11].

THCa (Tetrahydrocannabinolic Acid)

Important chemically, low on direct human evidence. THCa is the acidic precursor that may represent large share of raw plant THC content. It decarboxylates to THC during heating and can change during storage/processing [12]. Itself doesn’t produce psychoactive effects in humans, but only if it stays acidic and isn’t decarboxylated [12].

Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but not established human outcomes [12].

Delta-9 THC

Strongest human evidence of psychoactive cannabinoids, clearest adverse-effect burden. NCCIH identifies relevance to chemo nausea, HIV/AIDS appetite, some MS/pain outcomes, while stressing other uses remain uncertain [1].

Pain evidence: 2022 systematic review found high-THC or comparable THC:CBD products may provide short-term pain benefit but increase dizziness, sedation, nausea, and discontinuation due to adverse events [13].

Pharmacokinetics: Inhaled THC: effects within seconds-minutes, peak 15-30 minutes, taper over few hours. Oral THC: later onset, later peak, longer duration [14].

Mental health risk: 2025 systematic review found consistent unfavorable associations with psychosis/schizophrenia and cannabis use disorder, plus concerning signals for anxiety/depression in non-therapeutic settings [15].

CBN (Cannabinol)

Weak human evidence; marketing ahead of data. Marketed for sleep/sedation, but clinical support is far thinner than reputation suggests [16][17]. 2021 narrative review screened 99 human-study abstracts, reviewed eight full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography that substantiate strong sleep claims [16]. 2024 updated review concluded cannabinoid sleep research still doesn’t match real-world use scale, needing better-designed, adequately powered trials [17].

CBC (Cannabichromene)

Emerging, intriguing, overwhelmingly preclinical. 2024 focused review describes distinct pharmacodynamics/pharmacokinetics, highlighting antinociceptive, antibacterial, and anti-seizure as interesting research targets [18]. 2021 review literature reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance, but not strong patient-facing evidence [19]. Safety caveat: Over-the-counter CBC products sold despite little clinical efficacy/safety evidence [18].

Terpenes: The Aromatic Dimension

Limonene

Mostly review/preclinical. 2021 review describes multifunctional properties (antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory) but overwhelmingly from nonhuman/non-cannabis literature [21]. Safety note: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens [22].

Myrcene

Mostly preclinical, very limited human evidence. 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties but explicitly states human studies lacking [23]. Often invoked as proven sedative explaining “couch-lock”—stronger claim than evidence supports [20][23].

Caryophyllene

Most mechanistically interesting due to CB2 receptor agonism. 2021 review describes beta-caryophyllene as selective CB2 agonist, unusual and relevant pharmacologically [24]. Research themes: anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective, but human confirmation limited [24].

Pinene

Promising preclinical, weak human confirmation. 2021 review on pinene/linalool as brain health medicines found antioxidant, anti-inflammatory, neuroprotective signals justifying future study but emphasized lack of well-designed clinical trials [25]. Claims about memory improvement and counteracting THC cognitive effects remain hypotheses, not settled facts [20][25].

Linalool

Substantial preclinical interest, limited direct clinical confirmation. 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological/psychiatric contexts while emphasizing lack of robust human trials [25]. Separate review discusses possible antidepressant mechanisms but remains translational [26]. Safety: Oxidized linalool hydroperoxides are recognized allergens [22].

Humulene

Translationally interesting, early stage. 2024 scoping review of 340 articles found broad preclinical evidence for anti-inflammatory and other biologic effects, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27]. Valuable for hypothesis generation but doesn’t establish consistent human efficacy [27].

Terpinolene

Least clinically characterized. 2021 systematic review screened 2,449 records, included 57 studies, concluded terpinolene has range of reported biological effects but evidence base dominated by in silico, in vitro, and animal studies [28]. Recent entourage reviews frame terpene benefits as exploratory, not established clinical effects [20][28].

Research Limits and Interpretation for Kalawao County

1. Evidence is highly uneven—CBD/delta-9 THC support detailed statements; others require caution [1]-[29]
2. Extract/molecule/synthetic/terpene data aren’t interchangeable—common error letting one category stand for another
3. Minor cannabinoids are commercially interesting because underexplored, but claims often inflated
4. Product quality matters as much as molecule identity—labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent pharmacokinetics affect real-world interpretation [1][10][11][14]
5. THCa chemistry changes with storage/heating, converting to THC and altering exposure profile [12]

Common Overstatements to Avoid (Kalawao County Edition)

• Overstatement: “CBN is a clinically proven sleep aid”
  More accurate: Sleep evidence for CBN remains weak with no strong validated-trial base [16][17]
• Overstatement: “Myrcene makes you sleepy”
  More accurate: Preclinical bioactivity plausible but direct human proof for sedation limited [20][23]
• Overstatement: “Terpenes have proven entourage effects”
  More accurate: Entourage hypotheses influential but robust clinical proof limited and compound-specific [20][29]
• Overstatement: “THCa is always non-psychoactive”
  More accurate: THCa isn’t THC, but heating converts it to THC, changing effective exposure [12]
• Overstatement: “Delta-8 is safe because hemp-derived”
  More accurate: Delta-8 is psychoactive with incomplete safety characterization and manufacturing concerns [9]-[11]

Our Product Formulas: Complete Transparency

RSO Sublingual Oil — $129.99

Cannabinoid	Amount
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16,590 mg

• Live Terpenes: 5%
• Format: 30 mL bottle
• Active per mL: 553 mg
• Onset: 15-45 minutes (sublingual)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses per bottle: 40-60 (depending on serving)

For Kalawao County residents: This single bottle contains more total cannabinoids than most products on the market. The graduated dropper allows precise dosing in 0.1 mL increments—critical for titrating carefully in remote locations where medical support isn’t immediately available.

RSO Vape Cartridge — $49.99

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• 510-thread: Universal battery compatibility
• Onset: 1-2 minutes (fastest delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Auto-decarb: THCa converts instantly at vaping temperature (400-450°F)

For Kalawao County residents: Perfect for breakthrough pain or acute anxiety when you need relief within minutes, not hours. The compact size makes it easy to carry whether you’re working in the lo’i (taro patches) or traveling to Kualapuu.

Our Terpene Profile: Sensory and Therapeutic Dimensions

Same profile in both products:

• Limonene: Citrus-bright, mood-lifting
• Myrcene: Earthy, relaxing
• Caryophyllene (β-caryophyllene): Pepper/spice, CB2 activation
• Pinene: Forest-fresh, clarity
• Linalool: Floral lavender, calming
• Humulene: Earthy/woody, anti-inflammatory
• Terpinolene: Piney/fruity, complex

For Kalawao County residents: These aromas connect to familiar island scents—citrus from groves, pine from upland forests, lavender from gardens, pepper from local spice cultivation. The terpene profile makes the experience both effective and enjoyable.

When to Use Each Format in Kalawao County

Use Case	Recommended Format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability/discretion	Vape	Compact, no measuring
Precise dosing	Sublingual	0.1 mL increments
Daytime non-psychoactive	Sublingual (raw)	Zero impairment
Nighttime psychoactive	Sublingual (decarbed) or Vape	Full potency

Competitive Comparison: Why OilWell Stands Out

OilWell vs. Texas TCUP Dispensary RSO (e.g., Texas Original)

Dimension	TCUP Dispensary	OilWell
Cannabinoids	THC-only (~420 mg per 0.5 g)	7 cannabinoids (16,590 mg total)
CBG/CBN/CBC	0 mg	3,000 mg / 750 mg / 750 mg
Patient-controlled potency	No	Yes (THCa raw or decarbed)
Access requirements	Medical card + qualifying condition	Age 21+ only
Delivery	Physical dispensary only	Ships to Kalawao County
Farm Bill compliant	No	Yes

OilWell vs. Hemp CBD RSO (e.g., Lazarus Naturals)

Dimension	Lazarus (10 mL, 1,000 mg)	OilWell (30 mL, 16,590 mg)
Total cannabinoids	1,000 mg	16,590 mg
CBD content	~950 mg	4,500 mg
CBG/CBN/CBC	Minimal	3,000 mg / 750 mg / 750 mg
Delta-8 THC	0 mg	6,000 mg
Psychoactive option	No	Yes
THCa convertible	Minimal	1,500 mg → ~1,315 mg delta-9

The OilWell Difference for Kalawao County

Kalawao County is Hawaii’s smallest and most remote county, with a population under 100 people. Healthcare access is limited—the nearest major medical center is on Maui, requiring a flight or challenging boat crossing. This isolation makes our approach especially relevant:

Accessibility: You don’t need to travel to Oahu or Maui dispensaries. We ship directly to your Kalawao County address.

Community Values: Our open-source philosophy mirrors Molokai’s tradition of sharing knowledge and resources. If you can make it yourself, you have that right.

Evidence Transparency: In a small community where word travels fast, our commitment to honest education builds trust. We won’t tell you cannabis cures cancer—we’ll show you what the research actually says.

Patient Control: Whether you’re working in the Kalaupapa settlement, farming taro, or running a small business from Hoolehua, you can choose non-psychoactive or full-potency use based on your daily needs.

Safety: No toxic solvents. Lab-tested. Full COAs provided—essential when you can’t just walk into a dispensary to ask questions.

Order Information for Kalawao County

RSO Sublingual Oil: $129.99
RSO Vape Cartridge: $49.99

Shipping to Kalawao County, Hawaii:

• USPS Priority Mail: 2-3 business days
• FedEx/UPS Ground: 3-5 business days
• Discreet packaging, temperature-stable
• Tracking and signature options
• Full documentation for Hawaii agricultural inspection

Contact:

• Phone: (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/

The Bentley Recipe: Our Open-Source Promise

We published the CBD golden paste that saved Bentley’s life so any pet owner can make it:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 tsp freshly ground black pepper (for absorption)
• CBD oil (dose per pet size/veterinarian guidance)

Instructions: Mix turmeric and water over low heat into thick paste (7-10 minutes). Add coconut oil and pepper. Cool, store refrigerated up to 2 weeks. Mix with pet’s food once or twice daily.

This is our foundational commitment: the formula that started everything is free for anyone to use.

Our Media Record: Earned Recognition, Not Purchased

Seven ABC13 features across four years, five different reporters. Not a PR campaign—earned credibility through expertise, community action, and ethical leadership.

From the COVID vaccine giveaway ($35,000 in product) to proactively warning other operators about the Delta-8 ban, to sharing personal conviction history—our media record demonstrates consistency, transparency, and community commitment that can’t be bought.

The Bottom Line for Kalawao County

Kalawao County residents understand that healing comes in many forms—from modern medicine when available, from traditional practices passed down through generations, and sometimes from plants that have coexisted with humans for millennia. Our RSO formula honors that reality by providing:

• Transparency: Every ingredient, every milligram published
• Safety: Solvent-free, lab-tested, compliant with federal law
• Choice: Non-psychoactive raw use or full-potency activation—your decision
• Access: Ships directly to Kalawao County, no medical card required
• Honesty: Evidence-based education, not miracle cure claims

We are not here to replace your doctor. We’re here to provide a tool that may help when other tools have failed—backed by the same scientific standards we apply to everything we do.

For Kalawao County residents ready to explore RSO: Order today at oilwellcbd.com or call (832) 416-2816. We ship to Molokai, we answer questions directly, and we stand behind every product with the same commitment that made Bentley get up and walk again.

“I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” — Colin Valencia, OilWell Cannabis Founder